sb 203580 has been researched along with cyclosporin h in 1 studies
Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (cyclosporin h) | Trials (cyclosporin h) | Recent Studies (post-2010) (cyclosporin h) |
---|---|---|---|---|---|
3,489 | 4 | 1,137 | 62 | 0 | 20 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bylund, J; Dahlgren, C; Fu, H; Hellstrand, K; Karlsson, A; Mellqvist, UH; Pellmé, S | 1 |
1 other study(ies) available for sb 203580 and cyclosporin h
Article | Year |
---|---|
Cytochalasin B triggers a novel pertussis toxin sensitive pathway in TNF-alpha primed neutrophils.
Topics: Cyclosporine; Cytochalasin B; Humans; Imidazoles; Intracellular Signaling Peptides and Proteins; NADPH Oxidases; Neutrophil Activation; Neutrophils; Peptide Fragments; Pertussis Toxin; Protein Serine-Threonine Kinases; Pyridines; Receptors, Formyl Peptide; Receptors, G-Protein-Coupled; Respiratory Burst; Secretory Vesicles; Signal Transduction; Tumor Necrosis Factor-alpha | 2004 |